Beta-3 Agonist and Anti-muscarinic Agent for Sjogren's Syndrome With Overactive Bladder
Conditions: Sjogren's Syndrome; Overactive Bladder Syndrome Interventions: Drug: mirabegron; Drug: oxybutynin, tolterodine, solifenacin Sponsor: China Medical University Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Hospitals | Overactive Bladder | Overactive Bladder Syndrome | Oxybutynin | Research | Sjogren's Syndrome | VESIcare